ORLY
48
3
SLB
41
2
SNA
56
3
HD
43
8
UPS
51
6
STZ
42
2
SHW
42
5
MTB
38
4
JBHT
46
4
STX
34
2
FITB
36
3
AFL
34
6
TRV
34
4
LUV
45
3
PFG
27
7
JWN
72
9
DGX
28
4
DG
14
6
VFC
56
6
CMS
57
2
ORLY
48
3
SLB
41
2
SNA
56
3
HD
43
8
UPS
51
6
STZ
42
2
SHW
42
5
MTB
38
4
JBHT
46
4
STX
34
2
FITB
36
3
AFL
34
6
TRV
34
4
LUV
45
3
PFG
27
7
JWN
72
9
DGX
28
4
DG
14
6
VFC
56
6
CMS
57
2
Financhill
Back

iRhythm Technologies Quote, Financials, Valuation and Earnings

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.
Buy
58

IRTC
iRhythm Technologies

Last Price:
$90.51
Seasonality Move:
13.1%

7 Day Trial

ALL ACCESS PASS

$ 7

How to Turn the AI Energy Crisis into BIG Profits

And investors who move now into one technology could make a whole lot of money.

iRhythm Technologies Price Quote

$90.51
+0.12 (+3.25%)
(Updated: December 21, 2024 at 5:32 AM ET)

iRhythm Technologies Key Stats

Buy
58
iRhythm Technologies (IRTC) is a Buy
Day range:
$85.29 - $91.22
52-week range:
$55.92 - $124.12
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.01
P/B ratio:
39.42%
Volume:
461K
Avg. volume:
379.1K
1-year change:
-14.31%
Market cap:
$2.8B
Revenue:
$492.7M
EPS:
$-4.86

How Much Does iRhythm Technologies Make?

Data Unavailable

Is iRhythm Technologies Growing As A Company?

Data Unavailable

iRhythm Technologies Stock Price Performance

What Is iRhythm Technologies 52-Week High & Low?

iRhythm Technologies Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy iRhythm Technologies?

Data Unavailable

Is iRhythm Technologies Cash Flow Positive?

Data Unavailable

iRhythm Technologies Return On Invested Capital

Data Unavailable

iRhythm Technologies Earnings Date & Stock Price

iRhythm Technologies Competitors

  • Who Are iRhythm Technologies's Competitors?
    Below is a list of companies who compete with iRhythm Technologies or are related in some way:
    • Abbott Laboratories (ABT)
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

iRhythm Technologies Dividend Yield

Data Unavailable

iRhythm Technologies Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -122.32%
Revenue: 18.41% 0.56%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 105.58
Upside from Last Price: 16.81%

Major Shareholders

Data Unavailable